These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26502922)

  • 1. Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
    Giaginis C; Damaskos C; Koutsounas I; Zizi-Serbetzoglou A; Tsoukalas N; Patsouris E; Kouraklis G; Theocharis S
    BMC Gastroenterol; 2015 Oct; 15():148. PubMed ID: 26502922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
    J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.
    Giaginis C; Alexandrou P; Delladetsima I; Giannopoulou I; Patsouris E; Theocharis S
    Tumour Biol; 2014 Jan; 35(1):61-71. PubMed ID: 23873102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.
    Lehmann A; Denkert C; Budczies J; Buckendahl AC; Darb-Esfahani S; Noske A; Müller BM; Bahra M; Neuhaus P; Dietel M; Kristiansen G; Weichert W
    BMC Cancer; 2009 Nov; 9():395. PubMed ID: 19912635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
    von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
    Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
    Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
    Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma: Associations With Clinicopathologic Parameters, Tumor Proliferative Capacity, Patients' Survival, and Retinoid X Receptor Expression.
    Koutsounas I; Giaginis C; Alexandrou P; Zizi-Serbetzoglou A; Patsouris E; Kouraklis G; Theocharis S
    Pancreas; 2015 Oct; 44(7):1134-40. PubMed ID: 26355550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase (HDAC) encoding gene expression in pancreatic cancer cell lines and cell sensitivity to HDAC inhibitors.
    Ouaïssi M; Cabral S; Tavares J; da Silva AC; Mathieu Daude F; Mas E; Bernard J; Sastre B; Lombardo D; Ouaissi A
    Cancer Biol Ther; 2008 Apr; 7(4):523-31. PubMed ID: 18296916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
    He JC; Yao W; Wang JM; Schemmer P; Yang Y; Liu Y; Qian YW; Qi WP; Zhang J; Shen Q; Yang T
    Oncotarget; 2016 Nov; 7(46):75441-75456. PubMed ID: 27705912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma.
    Giaginis C; Koutsounas I; Alexandrou P; Zizi-Serbetzoglou A; Patsouris E; Kouraklis G; Theocharis S
    Neoplasma; 2015; 62(2):332-41. PubMed ID: 25591600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
    Klieser E; Urbas R; Swierczynski S; Stättner S; Primavesi F; Jäger T; Mayr C; Kiesslich T; Fazio PD; Helm K; Neureiter D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas.
    Krusche CA; Vloet AJ; Classen-Linke I; von Rango U; Beier HM; Alfer J
    Hum Reprod; 2007 Nov; 22(11):2956-66. PubMed ID: 17728353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer.
    Zhou W; Liang IC; Yee NS
    Cancer Biol Ther; 2011 Apr; 11(7):659-70. PubMed ID: 21301206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of histone deacetylase 2 is found in human gastric cancer.
    Song J; Noh JH; Lee JH; Eun JW; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    APMIS; 2005 Apr; 113(4):264-8. PubMed ID: 15865607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma.
    Zafar SF; Nagaraju GP; El-Rayes B
    Expert Opin Ther Targets; 2012 Jul; 16(7):707-18. PubMed ID: 22621256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.
    Fritzsche FR; Weichert W; Röske A; Gekeler V; Beckers T; Stephan C; Jung K; Scholman K; Denkert C; Dietel M; Kristiansen G
    BMC Cancer; 2008 Dec; 8():381. PubMed ID: 19099586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.